MIRACLE Act of 2025

HR 6220, the MIRACLE Act of 2025, directs the U.S. Department of Health and Human Services (HHS) to study neonatal abstinence syndrome (NAS), a condition affecting infants exposed to substances in utero. The study will examine NAS prevalence, barriers to accurate data collection under Medicaid (Title XIX), and the scope of available treatment services for affected infants and mothers. HHS must complete the study and submit a public report to Congress within three years of the bill’s enactment, detailing findings and recommendations. This bill directly affects HHS, state Medicaid programs, and pediatric transitional care facilities providing NAS treatment, but does not create new programs or funding.